Jorgelina Coppa
Papers
1
Total Citations
138
H-Index
1
About
Dr. Jorgelina Coppa is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for liver cancer treatment, particularly hepatocellular carcinoma (HCC). Her landmark 2022 study, "Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma," has garnered 138 citations, addressing a critical gap in surgical oncology by providing long-term oncologic outcomes data from Western high-volume centers. This work directly tackles the heated debate surrounding robotic liver resection (RLR), demonstrating its safety and efficacy compared to traditional open surgery. Dr. Coppa’s contributions are pivotal in shaping evidence-based practices for HCC management, offering patients less invasive options without compromising survival. Her research not only clarifies the role of robotics in hepatobiliary surgery but also sets a benchmark for future comparative studies. With a growing citation impact, Dr. Coppa is recognized as a key voice in the evolution of surgical oncology, bridging innovation and clinical rigor to improve outcomes for liver cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1